NF-κB inhibitory action of resveratrol: A probable mechanism of neuroprotection in experimental diabetic neuropathy

Biochemical and Biophysical Research Communications

Volumn 394, Issue 2, 2010, Pages 360-365

  Kumar, Ashutosh ^a   Sharma, Shyam S ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Cyclooxygenase 2 (COX 2); Diabetic neuropathy (DN); Inflammatory mediators; Inhibitory kappa B (I B ); Interleukin 6 (IL 6); Malondialdehyde (MDA); Nuclear factor kappa B (NF B); Tissue necrosis factor (TNF )

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CYCLOOXYGENASE 2; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PEROXYNITRITE; RESVERATROL; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; I KAPPA B; MALONALDEHYDE; NEUROPROTECTIVE AGENT; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG DOSE COMPARISON; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MOTOR NERVE CONDUCTION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SCIATIC NERVE; STREPTOZOCIN DIABETES; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; GLUCOSE BLOOD LEVEL; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALIA; RATTUS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD GLUCOSE; CYCLOOXYGENASE 2; DIABETIC NEUROPATHIES; I-KAPPA B PROTEINS; INTERLEUKIN-6; MALE; MALONDIALDEHYDE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950189559     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.03.014     Document Type: Article

References (26)

1. Vinik A.I., and Mehrabyan A. Diabetic neuropathies. Med. Clin. North Am. 88 (2004) 947-999 xi
2. Zhao Y., Ye W., Boye K.S., Holcombe J.H., Hall J.A., and Swindle R. Prevalence of other diabetes-associated complications and comorbidities and its impact on health care charges among patients with diabetic neuropathy. J. Diabetes Complications 24 (2010) 9-19
3. Kumar A., Kaundal R.K., Iyer S., and Sharma S.S. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci. 80 (2007) 1236-1244
4. Sayyed S.G., Kumar A., and Sharma S.S. Effects of U83836E on nerve functions, hyperalgesia and oxidative stress in experimental diabetic neuropathy. Life Sci. 79 (2006) 777-783
5. Negi G., Kumar A., Kaundal R.K., Gulati A., and Sharma S.S. Functional and biochemical evidence indicating beneficial effect of Melatonin and Nicotinamide alone and in combination in experimental diabetic neuropathy. Neuropharmacology 58 (2010) 585-592
6. Sharma S.S., Kumar A., and Kaundal R.K. Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy. Life Sci. 82 (2008) 570-576
7. Laura M., Mazzeo A., Aguennouz M., Santoro M., Catania M.A., Migliorato A., Calapai G., and Vita G. Immunolocalization and activation of nuclear factor-kappaB in the sciatic nerves of rats with experimental autoimmune neuritis. J. Neuroimmunol. 174 (2006) 32-38
8. Ho E., and Bray T.M. Antioxidants, NFkappaB activation, and diabetogenesis. Proc. Soc. Exp. Biol. Med. 222 (1999) 205-213
9. Cameron N.E., and Cotter M.A. Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway. Curr. Drug Targets 9 (2008) 60-67
10. Sousa M.M., Yan S.D., Stern D., and Saraiva M.J. Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-κB) activation. Lab. Invest. 80 (2000) 1101-1110
11. Andorfer B., Kieseier B.C., Mathey E., Armati P., Pollard J., Oka N., and Hartung H.P. Expression and distribution of transcription factor NF-kappaB and inhibitor IkappaB in the inflamed peripheral nervous system. J. Neuroimmunol. 116 (2001) 226-232
12. Karin M., Yamamoto Y., and Wang Q.M. The IKK NF-kappa B system: a treasure trove for drug development. Nat. Rev. Drug Discov. 3 (2004) 17-26
13. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., Prabhu V.V., Allard J.S., Lopez-Lluch G., Lewis K., Pistell P.J., Poosala S., Becker K.G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K.W., Spencer R.G., Lakatta E.G., Le Couteur D., Shaw R.J., Navas P., Puigserver P., Ingram D.K., de Cabo R., and Sinclair D.A. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006) 337-342
14. Zhu J., Yong W., Wu X., Yu Y., Lv J., Liu C., Mao X., Zhu Y., Xu K., Han X., and Liu C. Anti-inflammatory effect of resveratrol on TNF-alpha-induced MCP-1 expression in adipocytes. Biochem. Biophys. Res. Commun. 369 (2008) 471-477
15. Sharma S.S., Kumar A., Arora M., and Kaundal R.K. Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes. Free Radic. Res. 43 (2009) 400-408
16. Ohkawa H., Ohishi N., and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979) 351-358
17. Kim A.L., Labasi J.M., Zhu Y., Tang X., McClure K., Gabel C.A., Athar M., and Bickers D.R. Role of p38 MAPK in UVB-induced inflammatory responses in the skin of SKH-1 hairless mice. J. Invest. Dermatol. 124 (2005) 1318-1325
18. Lehmann G.L., Carreras F.I., Soria L.R., Gradilone S.A., and Marinelli R.A. LPS induces the TNF-alpha-mediated downregulation of rat liver aquaporin-8: role in sepsis-associated cholestasis. Am. J. Physiol. Gastrointest. Liver Physiol. 294 (2008) G567-G575
19. Obrosova I.G., Li F., Abatan O.I., Forsell M.A., Komjati K., Pacher P., Szabo C., and Stevens M.J. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. Diabetes 53 (2004) 711-720
20. Negi G., Kumar A., and Sharma S.S. Concurrent targeting of nitrosative stress-PARP pathway corrects functional, behavioral and biochemical deficits in experimental diabetic neuropathy. Biochem. Biophys. Res. Commun. 391 (2010) 102-106
21. Leonard S.S., Xia C., Jiang B.H., Stinefelt B., Klandorf H., Harris G.K., and Shi X. Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 309 (2003) 1017-1026
22. Yamamoto Y., and Gaynor R.B. Role of the NF-kappaB pathway in the pathogenesis of human disease states. Curr. Mol. Med. 1 (2001) 287-296
23. Singh U.P., Singh N., Singh B., Hofseth L.J., Price B.L., Nagarkatti M., and Nagarkatti P. Resveratrol (trans-3,5,4′-trihydroxystilbene) induces SIRT1 and down-regulates NF-{kappa}B activation to abrogate DSS-induced colitis. J. Pharmacol. Exp. Ther. 332 (2010) 829-839
24. Manna S.K., Mukhopadhyay A., and Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. J. Immunol. 164 (2000) 6509-6519
25. Bujalska M., Tatarkiewicz J., de Corde A., and Gumulka S.W. Effect of cyclooxygenase and nitric oxide synthase inhibitors on streptozotocin-induced hyperalgesia in rats. Pharmacology 81 (2008) 151-157
26. Kellogg A.P., Wiggin T.D., Larkin D.D., Hayes J.M., Stevens M.J., and Pop-Busui R. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes 56 (2007) 2997-3005